These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8566349)

  • 1. Difference spectra for inhibitor binding to monoamine oxidases.
    Sablin SO; Ramsay RR
    Biochem Soc Trans; 1995 Aug; 23(3):457S. PubMed ID: 8566349
    [No Abstract]   [Full Text] [Related]  

  • 2. Docking of novel reversible monoamine oxidase-B inhibitors: efficient prediction of ligand binding sites and estimation of inhibitors thermodynamic properties.
    Yelekçi K; Karahan O; Toprakçi M
    J Neural Transm (Vienna); 2007; 114(6):725-32. PubMed ID: 17401533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic behavior and reversible inhibition of monoamine oxidases--enzymes that many want dead.
    Tipton KF; Davey GP; McDonald AG
    Int Rev Neurobiol; 2011; 100():43-64. PubMed ID: 21971002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proposed structural basis of interaction of piperine and related compounds with monoamine oxidases.
    Rahman T; Rahmatullah M
    Bioorg Med Chem Lett; 2010 Jan; 20(2):537-40. PubMed ID: 19969454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous Production of Psilocybin and a Cocktail of β-Carboline Monoamine Oxidase Inhibitors in "Magic" Mushrooms.
    Blei F; Dörner S; Fricke J; Baldeweg F; Trottmann F; Komor A; Meyer F; Hertweck C; Hoffmeister D
    Chemistry; 2020 Jan; 26(3):729-734. PubMed ID: 31729089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The therapeutic potential of monoamine oxidase inhibitors.
    Youdim MB; Edmondson D; Tipton KF
    Nat Rev Neurosci; 2006 Apr; 7(4):295-309. PubMed ID: 16552415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectrometric evidence for the flavin-1-phenylcyclopropylamine inactivator adduct with monoamine oxidase N.
    Mitchell DJ; Nikolic D; Rivera E; Sablin SO; Choi S; van Breemen RB; Singer TP; Silverman RB
    Biochemistry; 2001 May; 40(18):5447-56. PubMed ID: 11331009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, structure-activity relationships and molecular modeling studies of new indole inhibitors of monoamine oxidases A and B.
    La Regina G; Silvestri R; Gatti V; Lavecchia A; Novellino E; Befani O; Turini P; Agostinelli E
    Bioorg Med Chem; 2008 Nov; 16(22):9729-40. PubMed ID: 18951803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of monoamine oxidase B by N-methyl-2-phenylmaleimides.
    Manley-King CI; Terre'Blanche G; Castagnoli N; Bergh JJ; Petzer JP
    Bioorg Med Chem; 2009 Apr; 17(8):3104-10. PubMed ID: 19324554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knowledge based identification of MAO-B selective inhibitors using pharmacophore and structure based virtual screening models.
    Boppana K; Dubey PK; Jagarlapudi SA; Vadivelan S; Rambabu G
    Eur J Med Chem; 2009 Sep; 44(9):3584-90. PubMed ID: 19321235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4-tert-Pentylphenoxyalkyl derivatives - Histamine H
    Łażewska D; Olejarz-Maciej A; Kaleta M; Bajda M; Siwek A; Karcz T; Doroz-Płonka A; Cichoń U; Kuder K; Kieć-Kononowicz K
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3596-3600. PubMed ID: 30404719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interactions of milacemide with monoamine oxidase.
    O'Brien EM; Tipton KF; McCrodden JM; Youdim MB
    Biochem Pharmacol; 1994 Feb; 47(4):617-23. PubMed ID: 8129740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of monoamine oxidase enzymatic activity by reversed-phase high performance liquid chromatography and inhibition by beta-carboline alkaloids occurring in foods and plants.
    Herraiz T; Chaparro C
    J Chromatogr A; 2006 Jul; 1120(1-2):237-43. PubMed ID: 16386263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of a series of unsaturated ketone derivatives as selective and reversible monoamine oxidase inhibitors.
    Choi JW; Jang BK; Cho NC; Park JH; Yeon SK; Ju EJ; Lee YS; Han G; Pae AN; Kim DJ; Park KD
    Bioorg Med Chem; 2015 Oct; 23(19):6486-96. PubMed ID: 26337020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromone-2- and -3-carboxylic acids inhibit differently monoamine oxidases A and B.
    Alcaro S; Gaspar A; Ortuso F; Milhazes N; Orallo F; Uriarte E; Yáñez M; Borges F
    Bioorg Med Chem Lett; 2010 May; 20(9):2709-12. PubMed ID: 20382016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling of substrate-binding region of the active site of monoamine oxidase A.
    Veselovsky AV; Medvedev AE; Tikhonova OV; Skvortsov VS; Ivanov AS
    Biochemistry (Mosc); 2000 Aug; 65(8):910-6. PubMed ID: 11002183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of selective inhibitors for computer modeling of the monoamine oxidase active site].
    Veselovskiĭ AV; Ivanov AS; Medvedev AE
    Vopr Med Khim; 1997; 43(6):527-36. PubMed ID: 9503570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. cis-Cyclopropylamines as mechanism-based inhibitors of monoamine oxidases.
    Malcomson T; Yelekci K; Borrello MT; Ganesan A; Semina E; De Kimpe N; Mangelinckx S; Ramsay RR
    FEBS J; 2015 Aug; 282(16):3190-8. PubMed ID: 25755053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural aspects of monoamine oxidase and its reversible inhibition.
    Wouters J
    Curr Med Chem; 1998 Apr; 5(2):137-62. PubMed ID: 9481038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selected C7-substituted chromone derivatives as monoamine oxidase inhibitors.
    Legoabe LJ; Petzer A; Petzer JP
    Bioorg Chem; 2012 Dec; 45():1-11. PubMed ID: 23064123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.